The report explores the growing connection between cybersecurity and insurance as businesses rely more on digital infrastructure. This relationship highlights the importance of protecting sensitive data and understanding potential risks in a rapidly evolving technological landscape.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
